- call +1-201-465-4211
- email sales@mrinsights.biz
Today many drug companies which have produced drugs with which the public is very familiar, like Plavix®, Lipitor® and Abilify®
Scope of the Report:
This report focuses on the Patent Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Patent Medicine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Pfizer Inc.
Otsuka Pharmaceutical
Merck
Novartis
Sanofi-Aventis
Bristol-Myers Squibb Co.
GSK
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Product Patents
Process Patents
Market Segment by Applications, can be divided into
Adult
Children
There are 15 Chapters to deeply display the global Patent Medicine market.
Chapter 1, to describe Patent Medicine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Patent Medicine, with sales, revenue, and price of Patent Medicine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Patent Medicine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Patent Medicine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Patent Medicine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Patent Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Product Patents
1.2.2 Process Patents
1.3 Market Analysis by Applications
1.3.1 Adult
1.3.2 Children
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Business Overview
2.1.2 Patent Medicine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Inc. Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Otsuka Pharmaceutical
2.2.1 Business Overview
2.2.2 Patent Medicine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Otsuka Pharmaceutical Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Patent Medicine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Patent Medicine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi-Aventis
2.5.1 Business Overview
2.5.2 Patent Medicine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi-Aventis Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb Co.
2.6.1 Business Overview
2.6.2 Patent Medicine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Co. Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GSK
2.7.1 Business Overview
2.7.2 Patent Medicine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GSK Patent Medicine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Patent Medicine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Patent Medicine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Patent Medicine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Patent Medicine Manufacturer Market Share in 2017
3.3.2 Top 6 Patent Medicine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Patent Medicine Market Analysis by Regions
4.1 Global Patent Medicine Sales, Revenue and Market Share by Regions
4.1.1 Global Patent Medicine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Patent Medicine Revenue and Market Share by Regions (2013-2018)
4.2 North America Patent Medicine Sales and Growth Rate (2013-2018)
4.3 Europe Patent Medicine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Patent Medicine Sales and Growth Rate (2013-2018)
4.5 South America Patent Medicine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Patent Medicine Sales and Growth Rate (2013-2018)
5 North America Patent Medicine by Countries
5.1 North America Patent Medicine Sales, Revenue and Market Share by Countries
5.1.1 North America Patent Medicine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Patent Medicine Revenue and Market Share by Countries (2013-2018)
5.2 United States Patent Medicine Sales and Growth Rate (2013-2018)
5.3 Canada Patent Medicine Sales and Growth Rate (2013-2018)
5.4 Mexico Patent Medicine Sales and Growth Rate (2013-2018)
6 Europe Patent Medicine by Countries
6.1 Europe Patent Medicine Sales, Revenue and Market Share by Countries
6.1.1 Europe Patent Medicine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Patent Medicine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Patent Medicine Sales and Growth Rate (2013-2018)
6.3 UK Patent Medicine Sales and Growth Rate (2013-2018)
6.4 France Patent Medicine Sales and Growth Rate (2013-2018)
6.5 Russia Patent Medicine Sales and Growth Rate (2013-2018)
6.6 Italy Patent Medicine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Patent Medicine by Countries
7.1 Asia-Pacific Patent Medicine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Patent Medicine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Patent Medicine Revenue and Market Share by Countries (2013-2018)
7.2 China Patent Medicine Sales and Growth Rate (2013-2018)
7.3 Japan Patent Medicine Sales and Growth Rate (2013-2018)
7.4 Korea Patent Medicine Sales and Growth Rate (2013-2018)
7.5 India Patent Medicine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Patent Medicine Sales and Growth Rate (2013-2018)
8 South America Patent Medicine by Countries
8.1 South America Patent Medicine Sales, Revenue and Market Share by Countries
8.1.1 South America Patent Medicine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Patent Medicine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Patent Medicine Sales and Growth Rate (2013-2018)
8.3 Argentina Patent Medicine Sales and Growth Rate (2013-2018)
8.4 Colombia Patent Medicine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Patent Medicine by Countries
9.1 Middle East and Africa Patent Medicine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Patent Medicine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Patent Medicine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Patent Medicine Sales and Growth Rate (2013-2018)
9.3 UAE Patent Medicine Sales and Growth Rate (2013-2018)
9.4 Egypt Patent Medicine Sales and Growth Rate (2013-2018)
9.5 Nigeria Patent Medicine Sales and Growth Rate (2013-2018)
9.6 South Africa Patent Medicine Sales and Growth Rate (2013-2018)
10 Global Patent Medicine Market Segment by Type
10.1 Global Patent Medicine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Patent Medicine Sales and Market Share by Type (2013-2018)
10.1.2 Global Patent Medicine Revenue and Market Share by Type (2013-2018)
10.2 Product Patents Sales Growth and Price
10.2.1 Global Product Patents Sales Growth (2013-2018)
10.2.2 Global Product Patents Price (2013-2018)
10.3 Process Patents Sales Growth and Price
10.3.1 Global Process Patents Sales Growth (2013-2018)
10.3.2 Global Process Patents Price (2013-2018)
11 Global Patent Medicine Market Segment by Application
11.1 Global Patent Medicine Sales Market Share by Application (2013-2018)
11.2 Adult Sales Growth (2013-2018)
11.3 Children Sales Growth (2013-2018)
12 Patent Medicine Market Forecast (2018-2023)
12.1 Global Patent Medicine Sales, Revenue and Growth Rate (2018-2023)
12.2 Patent Medicine Market Forecast by Regions (2018-2023)
12.2.1 North America Patent Medicine Market Forecast (2018-2023)
12.2.2 Europe Patent Medicine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Patent Medicine Market Forecast (2018-2023)
12.2.4 South America Patent Medicine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Patent Medicine Market Forecast (2018-2023)
12.3 Patent Medicine Market Forecast by Type (2018-2023)
12.3.1 Global Patent Medicine Sales Forecast by Type (2018-2023)
12.3.2 Global Patent Medicine Market Share Forecast by Type (2018-2023)
12.4 Patent Medicine Market Forecast by Application (2018-2023)
12.4.1 Global Patent Medicine Sales Forecast by Application (2018-2023)
12.4.2 Global Patent Medicine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Patent Medicine Picture
Table Product Specifications of Patent Medicine
Figure Global Sales Market Share of Patent Medicine by Types in 2017
Table Paten
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
